Welcome to LookChem.com Sign In|Join Free
  • or
H-CYS(BZL)-GLY-OH is a tripeptide composed of cysteine, benzyl ester, and glycine amino acids. Cysteine, a sulfur-containing amino acid, is crucial for disulfide bond formation in proteins. Glycine, the simplest and most abundant amino acid, plays a significant role in protein and molecule synthesis. The benzyl ester group, derived from benzyl alcohol, acts as a protecting agent in peptide synthesis, preventing unwanted reactions. H-CYS(BZL)-GLY-OH is vital for synthesizing and studying peptides and proteins, with potential applications in pharmaceuticals, biochemistry, and biotechnology.

7669-84-3

Post Buying Request

7669-84-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7669-84-3 Usage

Uses

Used in Pharmaceutical Industry:
H-CYS(BZL)-GLY-OH is used as a building block for the synthesis of therapeutic peptides and proteins. Its unique structure allows for the development of drugs with specific functions and properties.
Used in Biochemistry Research:
H-CYS(BZL)-GLY-OH is used as a research tool to study protein synthesis, folding, and interactions. Its presence in peptides can provide insights into protein structure and function.
Used in Biotechnology Applications:
H-CYS(BZL)-GLY-OH is used as a component in the design of novel biomaterials and biosensors. Its properties can be harnessed to create materials with specific biological activities or sensing capabilities.

Check Digit Verification of cas no

The CAS Registry Mumber 7669-84-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,6 and 9 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7669-84:
(6*7)+(5*6)+(4*6)+(3*9)+(2*8)+(1*4)=143
143 % 10 = 3
So 7669-84-3 is a valid CAS Registry Number.

7669-84-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[[(2R)-2-amino-3-benzylsulfanylpropanoyl]amino]acetic acid

1.2 Other means of identification

Product number -
Other names S-Benzyl-L-cysteinyl-glycin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7669-84-3 SDS

7669-84-3Relevant academic research and scientific papers

Initial intraorgan formation of mercapturic acid

Sano,Ikegami,Uesugi

, p. 1324 - 1328 (2007/10/03)

The disposition of S-benzyl-glutathione (BSG) in male Wistar rats was evaluated by the HPLC method to examine whether the kidney and liver contributed independently to the biosynthesis of S-benzyl-N-acetylcysteine (BNAc), a mercapturic acid (Chart 1). After intravenous injection, BSG was rapidly transported in both the kidney and the liver at a ratio of about 7:3. Simultaneously, a large amount of BNAc was found in both the kidney and the liver. In the kidney, S-benzyl-cysteine (BCys) reached a maximum concentration (Cmax) at 2 min after BSG injection, whereas BNAc reached Cmax within 3 to 5 min. The generation of BNAc was also observed in the liver. While renal BNAc reached Cmax within 3 to 5 min, hepatic BNAc reached Cmax around 5 min after BSG injection. Moreover, the elimination half-life of the BNAc after intravenous injection of the BSG was equivalent to that observed after intravenous injection of the BNAc itself. These results demonstrate that the kidney contributes to the initial intraorgan generation of BNAc and that this mercapturic acid is also synthesized in the liver and preferentially excreted into urine.

Preparation of peptides and cephalosporins

-

, (2008/06/13)

An improved process for producing a peptide and a cephalosporin which comprises treating a phosphoramide derivative of the formula: STR1 wherein R1 and R2 are each an alkyl group, a cycloalkyl group, an aryl group or an aralkyl group

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7669-84-3